
Exoskeleton Market
Exoskeleton Market Size, Share, Competitive Landscape and Trend Analysis Report by Mobility, Technology, Extremity and End-User Industry: Global Opportunity and Industry Forecast (2025-2030).
Report ID:
1052
Industry:
Electronics
Published on:
Sept 2025
Exoskeleton Market Overview
Exoskeleton Market had a value of USD 458.25 Million in 2024 and expected it to hit USD 1,205.26 Million by 2030, with a CAGR of 17.5 % during the forecast period. Exoskeleton Market was growing rapidly in 2024 across a wide range of industries, from manufacturing floors to rehabilitation clinics and even space missions, thanks to emerging evidence of considerable performance advantages and increased user engagement. In one automotive industry study, 42 actual operators took part in ergonomics experiments, which revealed that passive upper-limb exoskeletons increased static posture endurance by about 66 seconds (a 52.5% improvement over baseline), while precision jobs saw a 17.5% increase in completion rates. Lower-limb exoskeleton research focuses on material innovation (aluminum alloys, carbon fiber, titanium), additive manufacturing (especially 3D-printed orthoses), and actuation systems (electric motors, hydraulic/pneumatic, and compliant actuators), with design trends favoring lighter, more ergonomic, and customizable devices. NASA's X1 exoskeleton for in-space counter measures exhibits technological convergence by producing more than 300 Nm of peak torque per joint in a small yet adjustable device designed for resistance training and musculoskeletal monitoring in microgravity conditions.
By 2024, the exoskeleton market was achieved new levels of innovation and usefulness. Ekso Bionics received Medicare funding for its Indego Personal system and intends to deliver GaitCoach software in early 2024 to improve gait treatment outcomes. Honda's passive industrial exosuit was employed in 24% of global automotive plants, and Cyberdyne's HAL deployments have increased by 31% in Asia, expanding the company's presence in neurorehabilitation. In defense, ReWalk Robotics relaunched as Lifeward and expanded its product line to include rehabilitation and antigravity technology.
In South Korea, KAIST's WalkON Suit F1, a self-positioning, powered exoskeleton, earned news for assisting paraplegics in walking, climbing stairs, and even moving sideways via autonomous locking and environmental sensing. Meanwhile, Fourier Intelligence had unveiled an enhanced GR-2 model for late 2024, which was featured a 63 kg humanoid exoskeleton with 53 degrees of freedom, a detachable battery, and improved task capabilities. The implementation of AI-powered controls in medical and industrial settings significantly improves responsiveness, customization, and safety.

This extensive analysis by Jadhavar Business Intelligence Pvt Ltd provides consumers with a complete and actionable picture of the Global Exoskeleton Market, including market size, share, trends, and growth estimates from 2024 to 2030. It provides a complete overview of important locations and countries by Mobility, Technology, Extremity and End-User Industry. Clients receive comprehensive market dynamics, business tool analysis (PORTER and PESTLE), a Technology roadmap, and regulatory updates. The study also includes country-specific projections, competitive benchmarking, Company profiles, and M&A activity, all of which aid in strategic planning, market entry analysis, and competitor positioning.
Exoskeleton Market Dynamic’s
In 2024, the Exoskeleton Industry was set to advance on the strength of multiple growth drivers, ranging from proven performance gains to increasing user adoption and broader acceptance across key sectors. For example, industrial pilot trials show that workers wearing passive exoskeletal support devices have a 30% reduction in reported lower-back stiffness after just four weeks, while productivity in repeated lifting duties increased by around 18%. Early adopters in rehabilitation clinics reported that patients who used active lower-limb exoskeletons needed 12 fewer therapy hours on average to achieve comparable walking distance thresholds than those who used traditional methods. Wearable sensor advancements and control feedback have resulted in 20% faster response times in gait aid modes, providing users with more real-time flexibility. Meanwhile, economic efficiencies emerge as additive manufacturing reduces the production timetable for custom orthotic constructions by around 40%, allowing for increased institutional adoption. Collectively, these measures demonstrate how practical advances in clinical efficacy, workplace ergonomics, responsiveness, and manufacturing efficiency are propelling the exoskeleton market into 2024.
In 2024, the Exoskeleton Market was encountered considerable obstacles, mostly driven by its exorbitant costs of around USD 100,000 per device, which keep them out of reach for individual customers and emerging economies. Despite an estimated 180,000 persons suffering from spinal cord injuries globally, just three lower-limb exoskeletons (ReWalk, Ekso, and Indego) had received FDA certification, and each has limits for community or institutional use. While clinical studies demonstrate that 66-78% of SCI patients improved their gait, balance, cardiovascular health, and spasticity, there are still concerns about comfort, training-related injuries, and low long-term compliance. Similarly, in industrial applications, tests of devices such as the Laevo Flex and Paexo Back found a 38.8% reduction in Iliocostalis muscle activation; nevertheless, task-specific advantages and user discomfort, particularly in the legs, were identified as barriers to general adoption. Cost, regulatory constraints, comfort, and usability continued to be the principal challenges to exoskeleton market adoption.
The exoskeleton market gained momentum in 2024 as healthcare providers, industrial players, and defense organizations increasingly acknowledged its potential to enhance mobility, workplace safety, and operational efficiency. Exoskeletons was explored in rehabilitation clinics not only to improve walking and balance in patients with spinal cord injuries, but also to meet broader neurorehabilitation needs such as stroke recovery. The growing awareness of musculoskeletal disorders, which account for around 30% of all workplace injuries globally, was encouraged businesses to experiment with supportive exoskeletons to minimize fatigue and long-term health costs. Simultaneously, defense groups are promoting research into troop endurance and load-bearing capacities, laying the groundwork for the technology's application in other industries.
Exoskeleton Market Segment Analysis
The Exoskeleton Market is segmented into Mobility, Technology, Extremity and End-User Industry.
By Mobility
Based on Mobility segment the Exoskeleton Market is segmented into Mobile and Fixed/Stationary. Mobile has the largest market share of Exoskeleton Market, accounted for 62.4% of the total Mobility segment in 2024. This leadership is motivated by their versatility and vast application in the healthcare, industrial, and defense industries. Mobile exoskeletons, as opposed to fixed or stationary devices, allow freedom of mobility, making them suitable for spinal cord injury rehabilitation, industrial fatigue reduction, and military endurance development. Advances in lightweight materials, small actuators, and longer battery life have increased portability and user comfort, cementing their popularity over stationary counterparts that are nevertheless limited to specialized clinical or rehabilitative settings.

By Extremity
Based on Extremity Segment, the Exoskeleton Market is segmented into Upper Body, Lower Body and Full Body. Within the Extremity sector, Lower Body appears the dominated sub segment, accounted for approximately 65.5% of total market share in 2024 for Exoskeleton Market. This dominance arises from its broad usage in spinal cord and stroke therapy, where restoring gait and movement is a primary goal. Its dominance is supported by more regulatory approvals, verified clinical outcomes, and industrial and defense applications, making it the most financially viable and commonly used extremity type when compared to upper and full-body systems.
Exoskeleton Market Region analysis
North America led the Exoskeleton Market in 2024, accounting for 45.1% of Global Revenue of Exoskeleton market, Since the significant number of clinical users, focused R&D and finance, and a dense cluster of manufacturers and collaborations in healthcare and industry. The region's supremacy was bolstered by major government financing for rehabilitation technologies, early FDA clearance of medical exoskeletons, and global use in defense programs aimed at enhancing soldier mobility and reducing tiredness. Since the existence of major technology hubs and ongoing innovation in wearable robotics has bolstered North America's global dominance.
By 2024, Europe held 24.5% Shares of the total Exoskeleton Market, with a significant role in rehabilitation networks and industrial ergonomics programs. Asia Pacific accounted for approximately 19.4%, owing to increasing older populations and robot-friendly ecosystems in Japan, South Korea, and China. South America accounted approximately 5.8%, while the Middle East and Africa had a rate of about 5.3%. Although adoption was still in its early stages, it is gaining popularity in specialized clinics and industry pilot programs.
Exoskeleton Market Competitive Analysis
In 2024, the Exoskeleton sector was extremely competitive among medical, industrial, and defense companies. Ekso Bionics, ReWalk, and Ottobock/SuitX were the leaders in rehabilitation driven by its FDA approvals and clinical use, whereas Parker Hannifin, Sarcos, and Lockheed Martin excelled in defense and industrial applications with long-lasting, heavy-duty designs. Simultaneously, breakthrough businesses like Fourier Intelligence, CYBERDYNE, and DIH Medical rose to prominence in Asia and Europe thanks to their low-cost, lightweight technology. The competition centered mostly on regulatory approvals, ergonomic design, and strategic alliances.
North America dominated the market in 2024, accounting for the largest revenue share driven by its strong ecosystem of manufacturers, significant R&D funding, supportive regulatory pathways, and high adoption across healthcare and defense sectors. This environment gave North American companies a competitive edge, enabling faster commercialization and broader deployments compared to other regions.
Exoskeleton Market Scope:

Exoskeleton Market Key Players –
Ottobock / SuitX
ReWalk Robotics
Parker Hannifin
Hocoma
Bionik Laboratories
DIH Medical
RB3D
Rex Bionics
Lockheed Martin
Fourier Intelligence
Comau
Hyundai Motor Group — Robotics Lab
Frequently Ask Questions –
Who are the major Key players of Exoskeleton Market?
Ans - The Major Key players of Exoskeleton Market are Ekso Bionics, Ottobock / SuitX, CYBERDYNE, Inc., ReWalk Robotics and Sarcos Technology & Robotics.
Which Region accounted highest share of the Exoskeleton Market in 2024?
Ans - North America region accounted highest share of the Exoskeleton Market.
What was the market size of Exoskeleton Market in 2024?
Ans - In 2024, market size of the Exoskeleton Market is USD 458.25 Million.
Which Segment is expected to lead the market during forecast period?
Ans - Mobility Segment is the top segment hold the largest share in Exoskeleton Market during forecast period.
What will be the market size of Exoskeleton Market in 2030?
Ans - The market size of Exoskeleton Market in 2030 will be USD 1,205.26 Million.